Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 1. Pattern of response of common arrhythmias.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001146:Arrhythmia, Sinus / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy* / Q000209:etiology / Q000628:therapy; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D004071:Digitalis Glycosides / Q000009:adverse effects; D004554:Electric Countershock; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications; D010138:Pacemaker, Artificial; D011183:Postoperative Complications / Q000188:drug therapy; D011433:Propranolol / Q000627:therapeutic use; D013610:Tachycardia / Q000188:drug therapy; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy; D014693:Ventricular Fibrillation / Q000188:drug therapy; D014927:Wolff-Parkinson-White Syndrome / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D004071:Digitalis Glycosides; D011433:Propranolol